• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

3

CATEGORIES

  • 4
  • 3
  • 3
  • 1

PRICE

7
10
10
11

PUBLISHED

0
0
0
11

PRODUCT TYPE

7
4

Search "Halcygen Pharmaceuticals Limited" returned 11 results.

PRODUCT TITLE

HalcyGen Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

Halcygen Pharmaceuticals Limited - Product Pipeline Review - Q4 2010

Halcygen Pharmaceuticals Limited – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Halcygen Pharmaceuticals Limited - Product Pipeline Review - Q4 2010” provides...

December 2010
FROM
Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Detailed Product Pipeline Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Detailed Product Pipeline - Product Thumbnail Image

Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Detailed Product Pipeline

Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Detailed Product Pipeline provides up to date insight into company’s business description, product information, pipeline details including...

March 2011
FROM
Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Therapeutic Competitors Report Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Therapeutic Competitors Report - Product Thumbnail Image

Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Therapeutic Competitors Report

Mayne Pharma Group Limited (formerly Halcygen Pharmaceuticals)-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each...

March 2011
FROM

Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth

GBI Research, the leading business intelligence provider, has released its latest research “Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small...

April 2012
FROM

Onychomycosis (Tinea unguium) Global Clinical Trials Review, H1, 2012

Onychomycosis (Tinea unguium) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Onychomycosis (Tinea unguium) Global Clinical Trials Review, H1, 2012" provides data...

January 2012
FROM

Onychomycosis Global Clinical Trials Review, Q1, 2011

Onychomycosis Global Clinical Trials Review, Q1, 2011 Summary Our clinical trial report, “Onychomycosis Global Clinical Trials Review, Q1, 2011" provides data on the Onychomycosis clinical trial scenario....

April 2011
FROM

Sinusitis - Pipeline Review, Q4 2010

Sinusitis - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Sinusitis Pipeline Review, Q4 2010”, provides an overview of the Sinusitis therapeutic pipeline. This report provides information...

December 2010
FROM

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2011

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2011', provides an overview of the Onychomycosis (Tinea...

October 2011
FROM

Schizophrenia - Pipeline Review, Q4 2010

Schizophrenia - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Schizophrenia Pipeline Review, Q4 2010”, provides an overview of the Schizophrenia therapeutic pipeline. This report provides...

December 2010
FROM

Major Depressive Disorder - Pipeline Review, Q4 2010

Major Depressive Disorder - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Major Depressive Disorder Pipeline Review, Q4 2010”, provides an overview of the Major Depressive Disorder therapeutic...

December 2010
FROM
Loading Indicator